Liberty Biopharma Inc (CVE:LTY – Get Free Report)’s share price passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares traded.
Liberty Biopharma Stock Performance
The stock has a market capitalization of C$21.54 million and a PE ratio of -12.66. The company has a debt-to-equity ratio of 8.19, a current ratio of 0.12 and a quick ratio of 0.12. The business’s fifty day moving average price is C$2.00 and its 200-day moving average price is C$2.00.
Liberty Biopharma Company Profile
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Featured Articles
- Five stocks we like better than Liberty Biopharma
- Dividend Payout Ratio Calculator
- MP Materials: Rare Earth Elements Powering the EV Boom
- What is a SEC Filing?
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- Most active stocks: Dollar volume vs share volume
- Bloom Energy: Powering the Future With Decentralized Energy
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
